Full Recording | HCV Elimination Policy Forum - APASL 2024

The HCV Elimination Policy Forum convened on Thursday, March 28th, from 1:40 - 5:00 PM JST during the 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL) in Kyoto, Japan. This special session brought together leading clinicians, health officials, civil society members, and other influential stakeholders to discuss lessons learned, including innovative strategies, for preventing, diagnosing, and treating HCV across Asia. A call to action was presented to strengthen hepatitis elimination efforts in Asia.
The HCV Elimination Policy Forum was convened for participants attending the APASL conference. Session recording will be available here.
Agenda
Opening Remarks
- Dr. John Ward, Coalition for Global Hepatitis Elimination, United States
- Prof. Naoya Kato, Chiba University, Japan
- Video Message | Minister Keizo Takemi, Ministry of Health, Labour and Welfare of Japan, Japan
1. Updates on Progress towards HCV Elimination | Moderator: Prof. Naoya Kato, Chiba University, Japan
- Status of HCV Elimination Globally & in Asia | Dr. Philippa Easterbrook, World Health Organization
- National Advances towards HCV Elimination in Asia | Dr. John Ward, Coalition for Global Hepatitis Elimination, United States
2. HCV Elimination Initiatives to Reach Marginalized Communities in Asia Pacific Countries | Moderator: Prof. Junko Tanaka, Hiroshima University, Japan
- How to Reach and Treat PWUD Patients | Prof. Grace Wong, The Chinese University of Hong Kong, Hong Kong
- Simplification of HCV Care in Singapore | Prof. Yew Kuo Chao, Tan Tock Seng Hospital, Singapore
- Discussion
3. General Population HCV Elimination Initiatives in Asia Pacific Countries | Moderator: Prof. Ming-Lung Yu, National Sun Yat-sen University, Taiwan
- Screening and Testing of Persons with Diabetes | Prof. Tsung-Hui Hu, Chang Gung Memorial Hospital, Taiwan
- HCV Screening Strategies for the General Population in Japan | Prof. Tadashi Ikegami, Tokyo Medical University; Ibaraki Medical Center, Japan
- HCV National Screening and Elimination Strategies in Korea | Prof. Jonggi Choi, Asan Medical Center, University of Ulsan College of Medicine, Rep. of Korea
Special Lecture | DAA-induced Paradigm Shift in HCV High Endemic Area of Japan | Prof. Masao Omata, Yamanashi Central and Kita Hospitals, Japan
- Discussion
Call to Action & Closing Remarks | Dr. John Ward, Coalition for Global Hepatitis Elimination, United States